Market Currents
ThinkEquity initiates coverage on a slew of drug developers with a Buy rating this morning:...
-
Friday, June 29, 2012, 12:41 PM ETThinkEquity initiates coverage on a slew of drug developers with a Buy rating this morning: Navidea (NAVB +3.7%), BioMarin (BMRN +4.5%), Corcept Therapeutics (CORT +4%), Medivation (MDVN +5.2%), Amicus Theraputics (FOLD +2%), Raptor Pharmaceuticals (RPTP +0.2%), Synageva BioPharma (GEVA +3.2%), Aegerion (GEVA +3.7%).
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
